| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2025 | May 7, 2025 | Organon & Co. | Executive VP, Corp. Dev. | Buy | 86.3 | +3,500 | 8.11% | ✗ | $28.8K |
| Mar 31, 2025 | Apr 2, 2025 | Organon & Co. | Executive VP, Corp. Dev. | Sell | 22.5 | -10,870 | -6.78% | ✗ | $157.7K |
| Feb 12, 2020 | Feb 14, 2020 | BIOGEN INC. | EVP, Corporate Development | Sell | 22.5 | -294 | -24.01% | ✗ | $97.5K |
| Jul 2, 2019 | Jul 5, 2019 | BIOGEN INC. | EVP, Corporate Development | Sell | 26.3 | -58 | -17.99% | ✗ | $13.7K |